The trend could be your friend with the Canadian marijuana stocks on our list
SmallCapPower | July 7, 2017: If you believe that a stock that is going up or down fast will continue that trend, it is worth checking out the marijuana stocks on our list. Today we have identified four Canadian marijuana stocks with the strongest price momentum in the industry. This means that their stock price is moving, and it is doing so at a fast pace. The price momentum industry rank is based off data from Thomson Reuters and ranks stocks based on the rate of change in their price. A 100 rank would mean the price momentum is higher than 100% of stocks in the same industry. Remember to check exactly which way a stock is moving before making an investment decision based on momentum.
OrganiGram Holdings Inc. (TSXV: OGI) – $2.21
Pharmaceuticals
OrganiGram Holdings Inc., formerly Inform Exploration Corp., is a Canada-based company, which operates through its subsidiary Organigram Inc. Organigram Inc. is a licensed medical marijuana producer as regulated by Health Canada under the Marijuana Medical Access Regulations (MMAR) of the Government of Canada.
- Market Cap: $228,657,483
- YTD Price Change: -23.8%
- Price Momentum Industry Rank: 93
Aphria Inc. (TSX: APH) – $5.36
Pharmaceuticals
Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company’s retail sales are sold primarily through the Company’s online store, as well as telephone orders. Its wholesale shipments are sold to other Medical Purposes Regulations (MMPR) Licensed Producers. It offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil.
- Market Cap: $744,198,751
- YTD Price Change: 6.3%
- Price Momentum Industry Rank: 93
Cronos Group Inc. (TSXV: MJN) – $1.83
Pharmaceuticals
Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company that operates two Licensed Producers (LPs) regulated within Health Canada’s Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd. are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals.
- Market Cap: $244,483,096
- YTD Price Change: 23.6%
- Price Momentum Industry Rank: 93
Canopy Growth Corp. (TSX: WEED) – $8.03
Pharmaceuticals
Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a diversified cannabis company. The Company, through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed’s commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year.
- Market Cap: $1,326,731,078
- YTD Price Change: -12.1%
- Price Momentum Industry rank: 93
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
